Literature DB >> 31298937

The evolution of nasopharyngeal carcinoma staging.

Rui Guo1, Yan-Ping Mao1, Ling-Long Tang1, Lei Chen1, Ying Sun1, Jun Ma1.   

Abstract

The prevalence of nasopharyngeal carcinoma is characterized by an unbalanced distribution: the disease is particularly prevalent in East and Southeast Asia. In this article, we review the evolution of the International Union Against Cancer/American Joint Committee on Cancer staging system for nasopharyngeal carcinoma. With the increasing using of newer imaging methods, more advanced radiotherapy techniques and systemic chemotherapy, we also discuss newer clinical features that might affect staging. Finally, we propose the future direction of staging and potential prognostic factors that have a major influence on the treatment outcomes of this disease.

Entities:  

Mesh:

Year:  2019        PMID: 31298937      PMCID: PMC6774596          DOI: 10.1259/bjr.20190244

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  81 in total

Review 1.  Staging of nasopharyngeal carcinoma--the past, the present and the future.

Authors:  Wai Tong Ng; Kam Tong Yuen; Kwok Hung Au; Oscar S H Chan; Anne W M Lee
Journal:  Oral Oncol       Date:  2013-07-06       Impact factor: 5.337

2.  Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.

Authors:  Vincent Grégoire; Kian Ang; Wilfried Budach; Cai Grau; Marc Hamoir; Johannes A Langendijk; Anne Lee; Quynh-Thu Le; Philippe Maingon; Chris Nutting; Brian O'Sullivan; Sandro V Porceddu; Benoit Lengele
Journal:  Radiother Oncol       Date:  2013-10-31       Impact factor: 6.280

3.  Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. American Joint Committee on Cancer.

Authors:  E Ozyar; F Yildiz; F H Akyol; I L Atahan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

4.  Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization.

Authors:  L M Weiss; L A Movahed; A E Butler; S A Swanson; H F Frierson; P H Cooper; T V Colby; S E Mills
Journal:  Am J Surg Pathol       Date:  1989-08       Impact factor: 6.394

5.  Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.

Authors:  Rui Guo; Ling-Long Tang; Yan-Ping Mao; Xiao-Jing Du; Lei Chen; Zi-Chen Zhang; Li-Zhi Liu; Li Tian; Xiao-Tong Luo; Yu-Bin Xie; Jian Ren; Ying Sun; Jun Ma
Journal:  Cancer       Date:  2018-10-23       Impact factor: 6.860

6.  Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Chun-Ta Liao; Sheung-Fat Ko; Feng-Yuan Liu; Shu-Chyn Chin; Kang-Hsing Fan; Cheng-Lung Hsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

7.  Tumor volume is not an independent prognostic factor in early-stage nasopharyngeal carcinoma treated by radiotherapy alone.

Authors:  Daniel T T Chua; Jonathan S T Sham; Lucullus H T Leung; K S Tai; Gordon K H Au
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-04-01       Impact factor: 7.038

8.  The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging.

Authors:  Yan-Ping Mao; Shao-Bo Liang; Li-Zhi Liu; Yong Chen; Ying Sun; Ling-Long Tang; Li Tian; Ai-Hua Lin; Meng-Zhong Liu; Li Li; Jun Ma
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

9.  Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma.

Authors:  Wei Jiang; Na Liu; Xiao-Zhong Chen; Ying Sun; Bin Li; Xian-Yue Ren; Wei-Feng Qin; Ning Jiang; Ya-Fei Xu; Ying-Qin Li; Jian Ren; William C S Cho; Jing-Ping Yun; Jing Zeng; Li-Zhi Liu; Li Li; Ying Guo; Hai-Qiang Mai; Mu-Sheng Zeng; Tie-Bang Kang; Wei-Hua Jia; Jian-Yong Shao; Jun Ma
Journal:  Mol Cancer Ther       Date:  2015-10-06       Impact factor: 6.261

10.  A comparison of staging systems for nasopharyngeal carcinoma.

Authors:  J S Cooper; R Cohen; R E Stevens
Journal:  Cancer       Date:  1998-07-15       Impact factor: 6.860

View more
  26 in total

1.  Advances in nasopharyngeal carcinoma-"West meets East".

Authors:  Melvin Lk Chua; Ying Sun; Stéphane Supiot
Journal:  Br J Radiol       Date:  2019-10       Impact factor: 3.039

2.  Improvement and prognosis analysis of nimotuzumab combined with TP regimen induction chemotherapy and sequential concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.

Authors:  Weihong Luan; Haozhan Yuan; Wei Hou; Jing Li; Liping Liu
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 3.  A practical overview of CT and MRI features of developmental, inflammatory, and neoplastic lesions of the sphenoid body and clivus.

Authors:  Cosimo Nardi; Davide Maraghelli; Michele Pietragalla; Elisa Scola; Luca Giovanni Locatello; Giandomenico Maggiore; Oreste Gallo; Maurizio Bartolucci
Journal:  Neuroradiology       Date:  2022-06-03       Impact factor: 2.995

4.  CircSOX9 acts as a molecular sponge of miR-485-3p to promote the progression of nasopharyngeal carcinoma.

Authors:  Yanbo Sun; Yun Liu; Zhihui Du; Liangqiang Zhou; Qingguo Chen; Hanqi Chu
Journal:  Aging (Albany NY)       Date:  2022-06-14       Impact factor: 5.955

5.  Parotid Gland Stem Cell Preservation during Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Dosimetric Analysis and Feasibility.

Authors:  Lirong Zheng; Qiaoli Mei; Yuxiang Gao; Fenglei Du; Lin Xiao; Gangfeng Wu
Journal:  J Oncol       Date:  2022-07-12       Impact factor: 4.501

6.  The Highly Expressed IFIT1 in Nasopharyngeal Carcinoma Enhances Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.

Authors:  Xuan Wu; Liping Lin; Fengrui Zhou; Shaokang Yu; Minhua Chen; Shubin Wang
Journal:  Mol Biotechnol       Date:  2022-01-17       Impact factor: 2.860

7.  Effect of high-quality nursing intervention on psychological emotion, life quality and nursing satisfaction of patients with nasopharyngeal carcinoma undergoing radiotherapy.

Authors:  Cui Li; Jianyu Duan
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

8.  Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma.

Authors:  Qiao Yang; Yue Hua Nie; Man Bo Cai; Zhi Min Li; Hong Bo Zhu; Ye Ru Tan
Journal:  Drug Des Devel Ther       Date:  2022-04-26       Impact factor: 4.319

9.  Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.

Authors:  Chaoyang Jiang; Hui Gao; Ling Zhang; Hua Li; Tao Zhang; Ji Ma; Bisheng Liu
Journal:  BMC Cancer       Date:  2020-07-17       Impact factor: 4.430

10.  Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma.

Authors:  Xiuying Sun; Jinhui Zhou; Zhicun Zhang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.